Johan Sandin Takes Office as AlzeCure Pharma Acting CEO
Johan Sandin takes office today as acting CEO of AlzeCure Pharma.
Related stories
Lowe's Companies Shares Hit 7-week High
Lowe's Companies shares increased to 204.54 USD, the highest since September 2026. Over the past 4 weeks, Lowe's Companies gained 10.84%, and in the last 12 months, it decreased 14
L impact | EQUITY | Oct 29, 2026, 03:03 PM UTC
Fortrea Reports Quarterly Results for Period Ended September 30
M impact | EQUITY | Oct 29, 2026, 03:03 PM UTC
Analysts Update Linde Price Targets After Q3 Results
Bernstein maintained an Outperform rating and a $562 price target; Mizuho raised its target to $583.
M impact | EQUITY | Oct 29, 2026, 03:03 PM UTC
Al Baha Reports Q3 Net Profit of SAR 2.7 Million
M impact | EQUITY | Oct 29, 2026, 03:02 PM UTC
Shell Posts Highest Quarterly Profit Since 2022, Raises Buyback
Shell reported third-quarter net profit of $10.81 billion, above analysts’ average estimate of $10.33 billion. Record refining margins and stronger LNG performance helped the resul
M impact | EQUITY | Oct 29, 2026, 03:01 PM UTC
Alphabet Shares Plunge More Than 10% After Earnings
Alphabet shares fell more than 10% Thursday morning, putting ETFs with large holdings in the company under pressure after its latest earnings report.
M impact | EQUITY | Oct 29, 2026, 03:01 PM UTC